INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 28 February 2013
Total net assets |
£141.8m |
NAV per share |
255.6p |
Share price |
216.5p |
Total value of unquoted investments |
£21.8m |
Total number of portfolio companies |
68 |
Cash |
(1)% NAV |
Cash committed and reserved to unquoted investments |
(5.4)% NAV |
Portfolio companies with < 1 year of cash |
15.42% NAV |
Top Ten Holdings
Company Name |
% NAV |
Celgene Amgen Gilead |
8.4 7.5 6.0 |
Onyx |
4.8 |
Aptiv |
4.2 |
Celldex |
3.6 |
Alexion |
3.2 |
Insulet |
3.2 |
Biogen |
2.9 |
Biomarin |
2.8 |
|
----------- |
Total |
46.6 |
Geographical Allocation |
% |
United States & Canada |
90 |
Europe |
10 |
Australia |
1 |
Cash |
(1) |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
86 |
Unquoted |
15 |
Cash |
(1) |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
21 MARCH 2013